Clinical features of immune checkpoint inhibitor-induced inflammatory arthritis differ in those treated with combination versus single agent therapy

被引：0
|
作者：
Cappelli, Laura
Bingham, Clifton
Brahmer, Julie
Forde, Patrick
Le, Dung
Lipson, Evan
Naidoo, Jarushka
Zhang, Lei
Shah, Ami
机构：
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2017年 / 5卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P445
引用
收藏
页数：2
相关论文
共 50 条
  • [41] THE ROLE OF IMMUNE CHECKPOINT INHIBITOR AS A SINGLE AGENT OR COMBINATION THERAPY IN ADVANCED THYROID CANCER
    Lee, Ju Young
    Park, Inae
    Nam, Myungwoo
    Low, Christmann
    Kim, Eugene
    Choi, Hansol
    Vagia, Elena
    Jung, Chan Mi
    Chae, Young Kwang
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A119 - A121
  • [42] A Case Report of Immune Checkpoint Inhibitor-Induced Aortitis Treated with Tocilizumab
    Bloomer, Chance H. H.
    Annabathula, Rahul V. V.
    Aggarwal, Vanya
    Upadhya, Bharathi
    Lycan, Thomas W. W.
    CASE REPORTS IN IMMUNOLOGY, 2022, 2022
  • [43] Comparison of immune checkpoint inhibitor-induced arthritis and reactive arthritis to inform therapeutic strategy
    Jensen, Anders Kirkegaard
    Chatzidionysiou, Katerina
    Torp, Christopher Kirkegaard
    Sorensen, Anne Sofie
    Tenstad, Helene Broch
    Schafer, Valentin S.
    Kostine, Marie
    Jacobsen, Soren
    Leipe, Jan
    Kragstrup, Tue Wenzel
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 148
  • [44] Clinical outcomes of patients with corticosteroid refractory immune checkpoint inhibitor-induced enterocolitis treated with infliximab
    Alexander, James L.
    Ibraheim, Hajir
    Sheth, Bhavisha
    Little, Jessica
    Khan, Muhammad Saheb
    Richards, Camellia
    Hunter, Nikki
    Chauhan, Dharmisha
    Ratnakumaran, Raguprakash
    McHugh, Kathleen
    Pinato, David J.
    Nathan, Paul
    Choy, Julia
    Crusz, Shanthini M.
    Furness, Andrew
    Turajlic, Samra
    Pickering, Lisa
    Larkin, James
    Teare, Julian P.
    Papa, Sophie
    Speight, Ally
    Sharma, Anand
    Powell, Nick
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (07)
  • [45] Cancer Outcomes in Cancer Patients with Immune Checkpoint Inhibitor-induced Inflammatory Arthritis Treated with Glucocorticoids: Data from the CanRIO Retrospective Cohort
    Savarimuthu, Vanissa
    Ladouceur, Alexandra
    Terry, Oliver
    Roberts, Janet
    Pope, Janet
    Appleton, Thomas
    Hoa, Sabrina
    Fifi-Mah, Aurore
    Maltez, Nancy
    Saltman, Alexandra
    Himmel, Megan
    Colmegna, Ines
    Cho, Lindsay
    Schmidt, Emma
    Berger, Claudie
    Barnetche, Thomas
    Arreola, Lourdes Gonzalez
    Ye, Carrie
    Jamal, Shahin
    Hudson, Marie
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 2077 - 2080
  • [46] Clinical and immune phenotypes associated with immune checkpoint inhibitor-induced autoimmune diabetes
    Ruiz-Esteves, Karina Nicole
    Shank, Kaitlyn
    Ouyang, Tianqi
    Colling, Caitlin
    Zubiri, Leyre
    Villani, Alexandra-Chloe
    Reynolds, Kerry Lynn
    Rengarajan, Michelle
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [47] Immune Checkpoint Inhibitor-induced Thyroid Disorders: A Single Center Experience
    Patrizio, Armando
    Fallahi, Poupak
    Antonelli, Alessandro
    Ferrari, Silvia Martina
    CURRENT PHARMACEUTICAL DESIGN, 2023, 29 (04) : 295 - 299
  • [48] Immunosuppression use and clinical outcomes in patients with immune checkpoint inhibitor -induced inflammatory arthritis
    Cappelli, Laura
    Bingham, Clifton
    Brahmer, Julie
    Forde, Patrick
    Le, Dung
    Lipson, Evan
    Naidoo, Jarushka
    Zheng, Lei
    Shah, Ami
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [49] Clinicopathologic Features of Checkpoint Inhibitor-Induced Enteritis: A Single Institution Experience
    Sharifai, Nima
    Byrnes, Kathleen
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 767 - 767
  • [50] Clinicopathologic Features of Checkpoint Inhibitor-Induced Enteritis: A Single Institution Experience
    Sharifai, Nima
    Byrnes, Kathleen
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 767 - 767
12345